Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1.
Tanaka M, Yamakage H, Muranaka K, Yamada T, Araki R, Ogo A, Matoba Y, Watanabe T, Saito M, Kurita S, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Matsumoto M, Nishimura M, Kusakabe T, Wada H, Hasegawa K, Kotani K, Noda M, Satoh-Asahara N. Tanaka M, et al. Among authors: yamakage h. Front Endocrinol (Lausanne). 2022 May 3;13:880148. doi: 10.3389/fendo.2022.880148. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35592778 Free PMC article.
A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome.
Kotani K, Satoh N, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Yamakage H, Yamada K, Hattori M, Shimatsu A; Japan Obesity and Metabolic Syndrome Study Group. Kotani K, et al. Among authors: yamakage h. Atherosclerosis. 2009 Jun;204(2):526-31. doi: 10.1016/j.atherosclerosis.2008.09.017. Epub 2008 Sep 27. Atherosclerosis. 2009. PMID: 19007930
Remnant-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome.
Kotani K, Asahara-Satoh N, Kato Y, Araki R, Himeno A, Yamakage H, Koyama K, Tanabe M, Oishi M, Okajima T, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group. Kotani K, et al. Among authors: yamakage h. J Clin Lipidol. 2011 Sep-Oct;5(5):395-400. doi: 10.1016/j.jacl.2011.08.001. Epub 2011 Aug 12. J Clin Lipidol. 2011. PMID: 21981841
Lectin-like oxidized low-density lipoprotein receptor-1 plays an important role in vascular inflammation in current smokers.
Takanabe-Mori R, Ono K, Wada H, Takaya T, Ura S, Yamakage H, Satoh-Asahara N, Shimatsu A, Takahashi Y, Fujita M, Fujita Y, Sawamura T, Hasegawa K. Takanabe-Mori R, et al. Among authors: yamakage h. J Atheroscler Thromb. 2013;20(6):585-90. doi: 10.5551/jat.16436. Epub 2013 May 10. J Atheroscler Thromb. 2013. PMID: 23665840 Free article.
Analysis of factors that determine weight gain during smoking cessation therapy.
Komiyama M, Wada H, Ura S, Yamakage H, Satoh-Asahara N, Shimatsu A, Koyama H, Kono K, Takahashi Y, Hasegawa K. Komiyama M, et al. Among authors: yamakage h. PLoS One. 2013 Aug 21;8(8):e72010. doi: 10.1371/journal.pone.0072010. eCollection 2013. PLoS One. 2013. PMID: 23991026 Free PMC article.
93 results